Ligand Pharmaceuticals (LGND) Revenue Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 5.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.55% |
| Dec 31, 2025 | 5.80% |
| Sep 30, 2025 | 24.93% |
| Jun 30, 2025 | -1.69% |
| Mar 31, 2025 | 7.48% |
| Dec 31, 2024 | -8.78% |
| Sep 30, 2024 | -4.61% |
| Jun 30, 2024 | -19.24% |
| Mar 31, 2024 | -12.72% |
| Dec 31, 2023 | -26.23% |
| Sep 30, 2023 | -7.74% |
| Jun 30, 2023 | -13.98% |
| Mar 31, 2023 | 9.87% |
| Dec 31, 2022 | 23.11% |
| Sep 30, 2022 | 33.65% |
| Jun 30, 2022 | 26.12% |
| Mar 31, 2022 | -5.66% |
| Dec 31, 2021 | -1.81% |
| Sep 30, 2021 | 9.34% |
| Jun 30, 2021 | -4.33% |
| Mar 31, 2021 | -6.03% |
| Dec 31, 2020 | 5.51% |
| Sep 30, 2020 | -2.87% |
| Jun 30, 2020 | -22.81% |
| Mar 31, 2020 | -16.10% |
| Dec 31, 2019 | -10.91% |
| Sep 30, 2019 | 4.69% |
| Jun 30, 2019 | 8.58% |
| Mar 31, 2019 | 13.62% |
| Dec 31, 2018 | 41.14% |
| Sep 30, 2018 | 37.15% |
| Jun 30, 2018 | 69.72% |
| Mar 31, 2018 | 56.67% |
| Dec 31, 2017 | 37.35% |
| Sep 30, 2017 | 45.02% |
| Jun 30, 2017 | 103.99% |
| Mar 31, 2017 | 52.10% |
| Dec 31, 2016 | 37.35% |
| Sep 30, 2016 | 18.46% |
| Jun 30, 2016 | 26.78% |
| Mar 31, 2016 | 36.52% |
| Dec 31, 2015 | 15.84% |
| Sep 30, 2015 | 40.55% |
| Jun 30, 2015 | 47.48% |
| Mar 31, 2015 | 37.35% |
| Dec 31, 2014 | 21.14% |
| Sep 30, 2014 | 37.65% |
| Jun 30, 2014 | 12.44% |
| Mar 31, 2014 | 60.00% |
| Dec 31, 2013 | 55.23% |
| Sep 30, 2013 | 18.57% |